Log In
Print this Print this

Tuberculosis vaccine (Mtb72F/AS02A) (GSK692342)

Also known as: 692342

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionTuberculosis vaccine consisting of Mtb72F antigen and AS02 adjuvant
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationTuberculosis
Indication DetailsPrevent tuberculosis (TB) infection
Regulatory Designation
PartnerAeras Global TB Vaccine Foundation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today